Speaker
Chief Executive Officer, Synthis Therapeutics
Dori Thomas-Karyat, Chief Executive Officer at Synthis Therapeutics, appears in the programmes of 2 conferences on kongre.net. Most recently: 3rd ADC Payload Summit (Boston, United States of America, 4–6 Nov 2026).
4–6 Nov 2026Boston, United States of America
9–10 Sept 2026Boston, United States of America
Chief Scientific Officer, Iksuda Therapeutics
Director, Oncology Drug Discovery, Takeda
Chief Scientific Officer, Hexagon Bio
Senior Principal Scientist, Oncology Innovation, GlaxoSmithKline
Chief Scientific Officer, Ryvu Therapeutics
Vice President, CanWell Pharma
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Science Partner, Flagship Pioneering
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Chief Business Officer, Nurix Therapeutics, Inc.
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Dori Thomas-Karyat, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].